ANGO vs CTAS · rev $292.5M vs P/E 51, rev $10.34B
AngioDynamics Inc (ANGO) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported CTAS revenue for 2025-05-31 was $10.34B. Net income was $1.81B. Revenue was up 7.7% from 2024-05-31 to 2025-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
ANGO currently screens at market cap $378.5M. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the ANGO and CTAS stock pages for the full models.
Not investment advice.